Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NTUS

Natus Medical (NTUS) Stock Price, News & Analysis

Natus Medical logo

About Natus Medical Stock (NASDAQ:NTUS)

Advanced Chart

Key Stats

Today's Range
$32.96
$32.96
50-Day Range
$32.96
$32.96
52-Week Range
$20.90
$33.93
Volume
1,514 shs
Average Volume
325,002 shs
Market Capitalization
$1.14 billion
P/E Ratio
89.08
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NTUS Stock News Headlines

New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.tc pixel
See More Headlines

NTUS Stock Analysis - Frequently Asked Questions

Natus Medical Incorporated (NASDAQ:NTUS) posted its quarterly earnings results on Thursday, November, 4th. The company reported $0.28 earnings per share for the quarter, missing analysts' consensus estimates of $0.30 by $0.02. The business had revenue of $113.88 million for the quarter, compared to the consensus estimate of $116.60 million. Natus Medical had a trailing twelve-month return on equity of 10.15% and a net margin of 2.65%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natus Medical investors own include Tesla (TSLA), Garmin (GRMN), Zoom Communications (ZM), Meta Platforms (META), M&T Bank (MTB), ServiceNow (NOW) and Piper Sandler Companies (PIPR).

Company Calendar

Last Earnings
11/04/2021
Today
9/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:NTUS
CIK
878526
Employees
1,400
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.37
Trailing P/E Ratio
89.08
Forward P/E Ratio
22.89
P/E Growth
N/A
Net Income
$13.18 million
Net Margins
2.65%
Pretax Margin
4.15%
Return on Equity
10.15%
Return on Assets
7.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.54
Quick Ratio
1.90

Sales & Book Value

Annual Sales
$473.44 million
Price / Sales
2.41
Cash Flow
$2.02 per share
Price / Cash Flow
16.34
Book Value
$12.44 per share
Price / Book
2.65

Miscellaneous

Outstanding Shares
34,581,000
Free Float
34,166,000
Market Cap
$1.14 billion
Optionable
Optionable
Beta
0.22

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:NTUS) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners